» Articles » PMID: 25078703

Immunodominant CD4+ T-cell Responses to Influenza A Virus in Healthy Individuals Focus on Matrix 1 and Nucleoprotein

Overview
Journal J Virol
Date 2014 Aug 1
PMID 25078703
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Antigen-specific CD4(+) T cells are essential for effective virus-specific host responses, with recent human challenge studies (in volunteers) establishing their importance for influenza A virus (IAV)-specific immunity. However, while many IAV CD4(+) T cell epitopes have been identified, few are known to stimulate immunodominant CD4(+) T cell responses. Moreover, much remains unclear concerning the major antigen(s) responded to by the human CD4(+) T cells and the extents and magnitudes of these responses. We initiated a systematic screen of immunodominant CD4(+) T cell responses to IAV in healthy individuals. Using in vitro expanded-multispecificity IAV-specific T cell lines and individual IAV protein antigens produced by recombinant vaccinia viruses, we found that the internal matrix protein 1 (M1) and nucleoprotein (NP) were the immunodominant targets of CD4(+) T cell responses. Ten epitopes derived from M1 and NP were definitively characterized. Furthermore, epitope sequence conservation analysis established that immunodominance correlated with an increased frequency of mutations, reflecting the fact that these prominent epitopes are under greater selective pressure. Such evidence that particular CD4(+) T cells are important for protection/recovery is of value for the development of novel IAV vaccines and for our understanding of different profiles of susceptibility to these major pathogens. Importance: Influenza virus causes half a million deaths annually. CD4(+) T cell responses have been shown to be important for protection against influenza and for recovery. CD4(+) T cell responses are also critical for efficient CD8(+) T cell response and antibody response. As immunodominant T cells generally play a more important role, characterizing these immunodominant responses is critical for influenza vaccine development. We show here that the internal matrix protein 1 (M1) and nucleoprotein (NP), rather than the surface proteins reported previously, are the immunodominant targets of CD4(+) T cell responses. Interestingly, these immunodominant epitope regions accumulated many mutations over time, which likely indicates increased immune pressure. These findings have significant implications for the design of T cell-based influenza vaccines.

Citing Articles

Inverted HA-EV immunization elicits stalk-specific influenza immunity and cross-protection in mice.

Zhu W, Dong C, Wei L, Kim J, Wang B Mol Ther. 2025; 33(2):485-498.

PMID: 39741410 PMC: 11852689. DOI: 10.1016/j.ymthe.2024.12.052.


Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach.

Gonzalez-Dominguez I, Puente-Massaguer E, Abdeljawad A, Lai T, Liu Y, Loganathan M NPJ Vaccines. 2024; 9(1):222.

PMID: 39551795 PMC: 11570629. DOI: 10.1038/s41541-024-01014-8.


Revealing novel and conservative T-cell epitopes with MHC B2 restriction on H9N2 avian influenza virus (AIV).

Jia Y, Wu Q, Li Y, Ma M, Song W, Chen R J Biol Chem. 2024; 300(6):107395.

PMID: 38768812 PMC: 11223079. DOI: 10.1016/j.jbc.2024.107395.


Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines.

Rak A, Isakova-Sivak I, Rudenko L Vaccines (Basel). 2023; 11(12).

PMID: 38140152 PMC: 10747533. DOI: 10.3390/vaccines11121747.


Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell Epitopes.

Hartman K, Steiner G, Siegel M, Looney C, Hickling T, Bray-French K Biology (Basel). 2023; 12(9).

PMID: 37759665 PMC: 10525474. DOI: 10.3390/biology12091265.


References
1.
Goulder P, Sewell A, Lalloo D, Price D, Whelan J, Evans J . Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation. J Exp Med. 1997; 185(8):1423-33. PMC: 2196285. DOI: 10.1084/jem.185.8.1423. View

2.
Menendez-Benito V, Neefjes J . Autophagy in MHC class II presentation: sampling from within. Immunity. 2007; 26(1):1-3. DOI: 10.1016/j.immuni.2007.01.005. View

3.
Swain S, McKinstry K, Strutt T . Expanding roles for CD4⁺ T cells in immunity to viruses. Nat Rev Immunol. 2012; 12(2):136-48. PMC: 3764486. DOI: 10.1038/nri3152. View

4.
Chaves F, Lee A, Nayak J, Richards K, Sant A . The utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infection. J Immunol. 2012; 188(9):4235-48. PMC: 3331894. DOI: 10.4049/jimmunol.1103640. View

5.
Roti M, Yang J, Berger D, Huston L, James E, Kwok W . Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus. J Immunol. 2008; 180(3):1758-68. PMC: 3373268. DOI: 10.4049/jimmunol.180.3.1758. View